News | Contrast Media Injectors | June 17, 2020

The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio

The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio

June 17, 2020 — Technavio has been monitoring the contrast injectors market and it is poised to grow by $613.47M during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The report, Contrast Injectors Market by Product and Geography - Forecast and Analysis 2020-2024, offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Contrast Injectors Market.

The market is concentrated, and the degree of concentration will accelerate during the forecast period. Bayer AG, Bracco Spa, General Electric Co., Guerbet, MEDTRON AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High-tech Co. Ltd., Shenzhen Seacrown Electromechanical Co. Ltd., Sino Medical-Device Technology Co. Ltd., and ulrich GmbH & Co. KG. are some of the major market participants. The increasing focus on R&D will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Increasing focus on R&D has been instrumental in driving the growth of the market.

For more information on this report: www.technavio.com

Related Content

News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Contrast Media

May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...

Time May 19, 2022
arrow
News | Radiation Oncology

May 19, 2022 — Robert L. Bard, M.D., an ITN editorial advisory board member, received one of the highest achievements of ...

Time May 19, 2022
arrow
News | Contrast Media

May 18, 2022 —According to ARRS’ American Journal of Roentgenology (AJR), to ensure that patients with emergent or life ...

Time May 18, 2022
arrow
News | Radiation Therapy

May 18, 2022 — RaySearch announced that the treatment control system RayCommand is in clinical use at the innovative ...

Time May 18, 2022
arrow
News | Women's Health

May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours ...

Time May 18, 2022
arrow
News | Radiation Oncology

May 17, 2022 — Radiation oncologists will meet with congressional leaders and staff today to ask for their support of ...

Time May 17, 2022
arrow
Videos | Proton Therapy

John C. Breneman, M.D., medical director of the Cincinnati Children's/UC Health Proton Therapy Center, and the principal ...

Time May 16, 2022
arrow
News | Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
News | Focused Ultrasound Therapy

May 12, 2022 — UVA Health and the Charlottesville-based Focused Ultrasound Foundation today announced the launch of the ...

Time May 12, 2022
arrow
Subscribe Now